Monopar Therapeutics
MNPR
#7031
Rank
NZ$1.15 B
Marketcap
NZ$171.85
Share price
2.90%
Change (1 day)
179.54%
Change (1 year)

Market capitalization of Monopar Therapeutics (MNPR)

Market cap: NZ$1.15 Billion

As of July 2026 Monopar Therapeutics has a market cap of NZ$1.15 Billion. This makes Monopar Therapeutics the world's 7031th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Monopar Therapeutics from 2019 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$1.15 B45.08%
2025NZ$0.79 B199.15%
2024NZ$0.26 B3216.75%
2023NZ$7.99 M-83.42%
2022NZ$48.22 M-18.54%
2021NZ$59.2 M-39.06%
2020NZ$97.14 M-62.77%
2019NZ$0.26 B

End of Day market cap according to different sources

On Jul 5th, 2026 the market cap of Monopar Therapeutics was reported to be:

NZ$1.15 Billion
by Nasdaq info icon info icon
NZ$1.15 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ$2.11 B 83.93%๐Ÿ‡บ๐Ÿ‡ธ USA